Mächler H, Metzler H, Sabin K, Anelli-Monti M, Rehak P, Rigler B, Gombotz H
Department of Anesthesiology, University of Graz, Austria.
Anesthesiology. 1994 Dec;81(6):1324-31. doi: 10.1097/00000542-199412000-00005.
Troponin-T is one of the contractile proteins of the myocardium. Its release into the circulation indicates various degrees of myocardial cell damage. Troponin-T may be measured in serum with a recently developed enzyme immunoassay. This immunoassay was used to evaluate the preoperative myocardial cell damage in patients with stable and unstable angina undergoing elective coronary artery bypass graft surgery, and it was compared with conventional assays of creatine kinase (CK) MB isoenzyme activity and mass.
Twenty-one patients with unstable angina and 31 with stable angina were studied. Troponin-T, CK-MB activity, and CK-MB mass were measured 24 h before anesthesia and surgery, immediately before induction of anesthesia, before and after cardiopulmonary bypass, at the end of surgery, and 24 h afterward.
In 90% (19 of 21) of the patients with unstable angina, troponin-T was increased 24 h before anesthesia (median 0.33 microgram/l, range 0.15-5.2 micrograms/l), whereas only 3% (1 of 31) of the patients with stable angina had increased values (median 0.0 microgram/l, range 0.0-0.53 microgram/l). The difference was statistically significant (P < 0.001). The same profile was found in patients with and without unstable angina immediately before induction of anesthesia (86% [18 of 21] and 0%, respectively) and before cardiopulmonary bypass (62% [13 of 21] and 0%, respectively). In contrast to troponin-T, CK-MB activity was increased in only 0-14% of patients with unstable angina, and CK-MB mass was increased in only 9-24%. After bypass troponin-T increased in both groups (P < 0.01), but there was no longer a statistically significant difference between the groups. Twelve percent (4 of 31) of the patients in the stable angina group and 28% (6 of 21) in the unstable group had major cardiac events (P not significant).
The study data suggest that many patients with unstable angina undergoing elective coronary artery bypass graft surgery have already increased troponin-T levels preoperatively, although conventional biochemical markers such as CK-MB activity and mass are at a normal range. Increased troponin-T and normal CK-MB concentrations may reflect some degree of ischemic myocardial cell damage. Because of the small number of patients in the study, the influence of preoperative myocardial injury on perioperative outcome could not be clarified.
肌钙蛋白T是心肌的收缩蛋白之一。其释放入循环表明心肌细胞有不同程度的损伤。可用最近开发的酶免疫测定法检测血清中的肌钙蛋白T。本免疫测定法用于评估择期冠状动脉搭桥手术患者术前的心肌细胞损伤,并与肌酸激酶(CK)MB同工酶活性和质量的传统检测方法进行比较。
研究了21例不稳定型心绞痛患者和31例稳定型心绞痛患者。在麻醉和手术前24小时、诱导麻醉前即刻、体外循环前后、手术结束时及术后24小时测定肌钙蛋白T、CK-MB活性和CK-MB质量。
90%(21例中的19例)不稳定型心绞痛患者在麻醉前24小时肌钙蛋白T升高(中位数0.33微克/升,范围0.15 - 5.2微克/升),而稳定型心绞痛患者中只有3%(31例中的1例)升高(中位数0.0微克/升,范围0.0 - 0.53微克/升)。差异有统计学意义(P < 0.001)。在诱导麻醉前即刻(分别为86% [21例中的18例]和0%)和体外循环前(分别为62% [21例中的13例]和0%),不稳定型心绞痛患者和无不稳定型心绞痛患者呈现相同的情况。与肌钙蛋白T不同,不稳定型心绞痛患者中只有0 - 14%的患者CK-MB活性升高,只有9 - 24%的患者CK-MB质量升高。体外循环后两组肌钙蛋白T均升高(P < 0.01),但两组之间不再有统计学显著差异。稳定型心绞痛组12%(31例中的4例)患者和不稳定型组28%(21例中的6例)患者发生了严重心脏事件(P无显著性)。
研究数据表明许多接受择期冠状动脉搭桥手术的不稳定型心绞痛患者术前肌钙蛋白T水平已经升高,尽管诸如CK-MB活性和质量等传统生化标志物在正常范围内。肌钙蛋白T升高而CK-MB浓度正常可能反映了一定程度的缺血性心肌细胞损伤。由于研究中的患者数量较少,术前心肌损伤对围手术期结局的影响尚不清楚。